Journal of Endocrine System and Regulation (JESR) is an international, peer-reviewed, open-access journal dedicated to advancing research in endocrine physiology, hormonal regulation, and their interdisciplinary applications in health and disease. Published quarterly online by GOSP, the journal bridges fundamental discoveries with clinical innovations to address metabolic, developmental, and therapeutic challenges.

Open Access Policy‌:
All articles in Journal of Endocrine System and Regulation are freely accessible under a full Open Access model. To encourage global knowledge exchange, the journal currently imposes ‌no Article Processing Charges (0 APC)‌ for authors.

‌Rapid Publication Timeline‌:

  • ‌Peer Review Efficiency‌: Manuscripts undergo rigorous peer review, with initial decisions provided to authors within ‌21 days‌ of submission.
  • ‌Acceptance to Publication‌: Accepted papers are published online within ‌14 days‌ of final acceptance, ensuring timely dissemination of critical engineering advancements.

‌Reviewer Recognition Program‌:
Reviewers who deliver timely, thorough, and constructive evaluations receive ‌APC Discount Vouchers‌ as acknowledgment of their contributions. These vouchers may be applied to reduce fees for future submissions in any journal within the GOSP network, fostering a collaborative scholarly community.

Scope and Vision:
Journal of Endocrine System and Regulation focuses on cutting-edge research in hormone signaling, endocrine disorders, metabolic homeostasis, and regenerative endocrinology. Key areas include:

  • Molecular mechanisms of hormone synthesis, secretion, and receptor interactions
  • Neuroendocrine integration and cross-talk with immune/metabolic systems
  • Novel therapeutics for diabetes, obesity, thyroid disorders, and reproductive endocrinology
  • Computational modeling of endocrine networks and precision diagnostics
  • Environmental endocrinology and endocrine-disrupting chemical impacts

The journal serves as a platform for interdisciplinary collaboration, uniting basic scientists, clinicians, and biotechnologists to tackle global challenges in metabolic health, aging, endocrine oncology, and personalized hormone therapies.